NCT07545525Not yet recruiting
HPV Testing as a Prevention of Cervical Dysplasia and Cancer Before Planned Subtotal Hysterectomy
HPV Testing as a Prevention of Cervical Dysplasia and Cervical Cancer Before Planned Subtotal Hysterectomy
Source: ClinicalTrials.gov · Last updated 22 Apr 2026
Brief summary (registry, in English)
Patients indicated for subtotal hysterectomy will be tested for High risk HPV and if the result is positive will undergo expert colposcopy and conisation if not indicated otherwise at the time of subtotal hysterectomy
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 14 Apr 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 30 Apr 2028
- Lead sponsor
- General University Hospital, Prague
- Diseases
- Cervical cancer
- NCT number
- NCT07545525
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Apr 2026 to the primary completion date, 30 Apr 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- negative HPV test in the last 3 years
Who the study is looking for
- age over 18
- indication for subtotal hysterectomy
- consent to provide conisation in case the HPV test result is positive
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.